XML 89 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Disclosure about Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Carrying Amounts and Estimated Fair Values of Financial Instruments
The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):
 
 
March 31, 2020
 
December 31, 2019
 
 
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
Financial assets:
 
 
 
 
 
 
 
 
Mortgage loans receivable
 
$
96,480

 
$
96,702

 
$
145,686

 
$
150,217

Other real estate loans receivable
 
124,748

 
123,101

 
124,696

 
128,512

Equity securities
 
8,034

 
8,034

 
15,685

 
15,685

Cash and cash equivalents
 
303,423

 
303,423

 
284,917

 
284,917

Restricted cash
 
89,643

 
89,643

 
100,849

 
100,849

Non-real estate loans receivable
 
373,179

 
418,221

 
336,854

 
379,239

Foreign currency forward contracts, interest rate swaps and cross currency swaps
 
210,837

 
210,837

 
18,554

 
18,554

 
 
 
 
 
 
 
 
 
Financial liabilities:
 
 
 
 
 
 
 
 
Borrowings under unsecured credit facility and commercial paper program
 
$
844,985

 
$
844,985

 
$
1,587,597

 
$
1,587,597

Senior unsecured notes
 
10,218,853

 
10,565,256

 
10,336,513

 
11,400,571

Secured debt
 
2,901,232

 
3,032,376

 
2,990,962

 
3,041,893

Foreign currency forward contracts, interest rate swaps and cross currency swaps
 
87,557

 
87,557

 
53,601

 
53,601

 
 
 
 
 
 
 
 
 
Redeemable OP unitholder interests
 
$
94,048

 
$
81,717

 
$
121,440

 
$
121,440


Summary of Items Measured at Fair Value on a Recurring Basis The following summarizes items measured at fair value on a recurring basis (in thousands):
 
 
Fair Value Measurements as of March 31, 2020
 
 
Total
 
Level 1
 
Level 2
 
Level 3
Equity securities
 
$
8,034

 
$
8,034

 
$

 
$

Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability) (1)
 
123,280

 

 
123,280

 

Totals 
 
$
131,314

 
$
8,034

 
$
123,280

 
$

(1) Please see Note 12 for additional information.